Semi-mechanistic PK and target-occupancy modeling to support dose justification for anti-PD-L1 clinical candidate CK-301 (TG-1501) in oncology patientsLin Lin,James Hilbert,Leonid Gorelik, Jian-Ping Tang,James Oliviero,Joshua Apgar,Lore Gruenbaum,John BurkeJOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
